Purchase Order 75D30122P15718
Award Date 9/23/22
Potential Completion Date 1/27/23
Potential Value $72K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Walnut Creek, CA 94598, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Centers for Disease Control and Prevention (CDC) in Pittsburgh has awarded a $57,490.00 firm fixed-price purchase order to Seegene USA Inc. Sales Division, a foreign-owned, for-profit small disadvantaged business, for the procurement of NOVAPLEX HPV28 DETECTION KITS. The award has an ultimate completion date of May 30, 2025 and supports the CDC's public health mission related to HPV screening and prevention. This order follows previous contract awards to Seegene USA Inc. Sales Division for...
- The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh has awarded a $85,500 firm fixed price purchase order to Seegene USA Inc. Sales Division, a foreign-owned, small disadvantaged business, for the delivery of an HPV Detection RUO Assay. This purchase order will provide the CDC Pittsburgh location with HPV test kits, reagents, and Novaplex II HPV28 detection kits to support the agency's public health mission related to HPV screening and prevention....
- The Centers for Disease Control and Prevention, under the Department of Health and Human Services, awarded a $16,070 firm fixed price purchase order to Miscellaneous Foreign Awardees for HAIN LIFESCIENCE GENOTYPE LINE PROBE ASSAY KITS AND REAGENTS. Performance will take place in Germany from September 26, 2023 through October 16, 2023. The award is likely associated with CDC's infectious disease diagnostic testing and surveillance programs. No subcontractors or set aside designations were...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $120,000.00 firm fixed price purchase order to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents, for the supply of NovaSeq 6000 SP Reagents. This contract supports the CDC's genomic sequencing and analysis capabilities, and does not have a set-aside designation. Illumina has previously provided a range of sequencing systems, consumables, and services to federal agencies...
- The Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents, for reagents to be used with Illumina's sequencing systems. The $219,192.00 contract does not have a set-aside designation and is intended to support the CDC's needs through August 31, 2022. Illumina has a history of providing sequencing equipment, consumables, and services to...
- The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded a $19,502 purchase order to Illumina, Inc. for ISEQ 100NGS kits. The firm fixed price contract has a period of performance of one day, September 6, 2023. The place of performance will be Illumina's location in Atlanta, Georgia. The CDC is likely procuring the next generation sequencing kits to support genomic surveillance efforts within its broader infectious disease programs. No...
- The Centers for Disease Control and Prevention (CDC) awarded Illumina, Inc. a $160,535.84 firm fixed price purchase order for reagents. The CDC, part of the Department of Health and Human Services, will utilize the reagents in Pittsburgh, Pennsylvania as part of its efforts to advance public health. Illumina will deliver the products from its facilities in San Diego, California by September 30, 2023 to support the CDC's disease prevention and health promotion activities. No set aside designation...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order to Promega Corporation for $142,450.00 to provide laboratory supplies. The contract, which does not have a set-aside designation, will run through September 30, 2017. Promega, a global life sciences company that manufactures and markets integrated systems and reagents for biological research and molecular diagnostics, has previously provided DNA analysis equipment,...
- The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded a $27,274.50 firm fixed price purchase order to Illumina, Inc. of San Diego, California for lab supplies and MiSeq reagent kits. The contract has no set-aside designation and requires completion by October 14, 2022. The MiSeq reagent kits will support the CDC's genomic sequencing work to advance public health goals such as disease surveillance and outbreak response. Illumina will deliver the...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price Blanket Purchase Agreement (BPA) call to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions, for the provision of lab supplies and reagents. The $149,220.97 contract does not have a set-aside designation and is intended to support the CDC's research and diagnostics needs in Atlanta, Georgia. Illumina has a history of providing a range of...